Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Oct 26, 2013; 5(10): 391-393
Published online Oct 26, 2013. doi: 10.4330/wjc.v5.i10.391
Published online Oct 26, 2013. doi: 10.4330/wjc.v5.i10.391
Medical management of connector pin thrombosis with the Amplatzer cardiac plug left atrial closure device
Diego Fernández-Rodríguez, Luca Vannini, Victoria Martín-Yuste, Salvatore Brugaletta, Rocío Robles, Ander Regueiro, Mónica Masotti, Manel Sabaté, Department of Cardiology, Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain
Author contributions: All authors contributed to the redaction of this manuscript.
Correspondence to: Victoria Martín-Yuste, MD, PhD, Department of Cardiology, Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/Villarroel 170, 08036 Barcelona, Spain. vmartiny@clinic.ub.es
Telephone: +34-934-2275519 Fax: +34-934-2275751
Received: May 26, 2013
Revised: September 9, 2013
Accepted: September 18, 2013
Published online: October 26, 2013
Processing time: 151 Days and 15.3 Hours
Revised: September 9, 2013
Accepted: September 18, 2013
Published online: October 26, 2013
Processing time: 151 Days and 15.3 Hours
Core Tip
Core tip: Percutaneous closure of the left atrial appendage has become an alternative treatment for patients with atrial fibrillation and with contraindications for chronic oral anticoagulation. Recently, the first case of connector pin thrombosis of the Amplatzer™ cardiac plug device for percutaneous left atrial appendage closure was described. Our work describes the management of this serious problem for the first time.